AEHR Test Systems (AEHR) is continuing to hit new 52-week lows due to Trio-Tech International (TRT) entering the Silicon Carbide and Gallium Nitride power module testing markets.
Despite AEHR rapidly collapsing it continues to trade with an enterprise value of 5.16x revenue!
The only reason AEHR trades at a higher multiple than TRT is due to the fact that AEHR has been promoting their Silicon Carbide and Gallium Nitride power module testing products.
Now that TRT is beginning to receive orders for their own competing products with hints of major new orders to come... TRT will be revalued to a higher multiple than AEHR.
Currently, TRT has trailing twelve-month revenue of $38.56 million and a multiple of 5.16x revenue will give TRT an enterprise value of $198.97 million plus net cash of $14.51 million equals a market cap of $213.48 million divided by 4.25 million shares outstanding equals $50.23 per share!
Even if TRT only rises in the upcoming weeks back to its 2007 high of $24.75 per share it will still be the #1 largest short-term gainer on any U.S. exchange!
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is meant for informational and educational purposes only and does not provide investment advice.
Preparing Americans for Hyperinflation
